Dominic Muston to present at Pricing Conference

News Release: March 7, 2008

Dominic Muston is based in Heron’s UK office and will present at CBI's Premier Bio/Pharmaceutical Forum on Effective Product Pricing and Modelling Strategies on May 10/11, 2008. Dominic is well published in the field of quantitative pricing research and will present on the following topic:

Examine the UK's value-based pricing models

In the UK, it has been recommended that the government reform the Pharmaceutical Price Regulation Scheme (PPRS) to replace profit and price controls with a value-based approach to pricing, reflecting clinical and therapeutic value to the patients and the society. In this session, discuss the value-based modeling structures used overseas to gain a better understanding of this approach.

- Review of UK pricing structure

- Weigh potential impact of value-based pricing on US pharmaceutical products

This topic is particularly timely, given the imminent change to pharmaceutical pricing mechanisms in the UK:

Ministers to scrap pricing deal on medicines

By Andrew Jack, FT.com

‘The government is poised to scrap the pricing mechanism for prescription medicines, setting a deadline of September 1 for the launch of a new deal with drug companies.'